Tag
A landmark randomized trial demonstrates that atorvastatin reduces major cardiovascular events in adults aged 70 and older without established cardiovascular disease but does not extend disability-free survival, highlighting nuanced conside
Healthcare professionals face significant gaps in cardiovascular prevention despite their critical role in care. The ESC Congress 2025 revealed prevalent modifiable risks, underuse of therapies, and subclinical atherosclerosis, underscoring
A landmark Norwegian study reveals that umbilical cord LDL-C levels overlap significantly between FH and non-FH newborns, making birth screening unreliable. In contrast, LDL-C becomes highly discriminative after age one, suggesting that uni
A double-blind randomized trial (PISCES) found daily fish-oil (EPA+DHA) 4 g reduced serious cardiovascular events by 43% versus corn-oil placebo in patients on maintenance hemodialysis over 3.5 years.
This systematic review and meta-analysis demonstrates that flavan-3-ol-rich foods significantly lower blood pressure and improve endothelial function, supporting their role in cardiovascular prevention, especially in individuals with elevat
Two massive randomized trials show high-dose flu vaccines reduce influenza-related and cardiorespiratory hospitalizations in older adults, reinforcing vaccination as a vital cardiovascular prevention strategy.
This review evaluates the DASH diet’s impact on major cardiovascular outcomes, synthesizing evidence from RCTs and highlighting its benefits on blood pressure and lipid profiles amid gaps in long-term clinical outcome data.
